Drug Database
Back to search

Poland· PL-100494680

ApoZolpin

A zolpidem product containing zolpidemi tartras, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 18 of our 19 countries.

ATC N05CF02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedApoZolpinATCN05CF02REGISTER NO.PL-100494680PACKS LISTED6CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about zolpidemi tartrasAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Zolpidem is registered in 18 of 19 countries.

Countries holding a registration under ATC N05CF02 (zolpidem), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 10 of them publish a price we can compare per daily dose
Search zolpidem products by name

Zolpidem · ATC N05CF02

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of zolpidem costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.11 in Spain to $0.89 in Switzerland — a ×8.4 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Zolpidem · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.89
  • FR France$0.18
  • ES Spain$0.11
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Zolpidemi tartras
Manufacturer
Delfarma Sp. z o.o.
Country
Poland (PL)
ATC code
N05CF02
ATC class
Zolpidem
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 6

  • gtin
    05909991534332
  • gtin
    05909991534349
  • gtin
    05909991534356
  • gtin
    05909991534363
  • gtin
    05909991534370
  • gtin
    05909991534387

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

392 interactions on record for zolpidem.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check zolpidem against other medicinesHow interaction checks work

Zolpidem · interactions on record

392 records

  • 4 severe
  • 129 moderate
  • 1 minor
  • 240 info

Most severe, free to view

  • MorphineN02AA01severe
  • MorphinN07BC09severe
  • HydrocodoneR05DA03severe
  • CodeineR05DA04severe

18 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under N05CF02

Zolpidem, as other registers publish it.

All zolpidem products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4581cb85-6617-4754-8473-4765c3638d72
GET /v1/drugs/4581cb85-6617-4754-8473-4765c3638d72?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "10 mg",
  "packaging": "05909991534332 ¦ Rp ¦ 153649\n10 tabl.\n05909991534349 ¦ Rp ¦ 153650\n20 tabl.\n05909991534356 ¦ Rp ¦ 153651\n30 tabl.\n05909991534363 ¦ Rp ¦ 153652\n50 tabl.\n05909991534370 ¦ Rp ¦ 153653\n60 tabl.\n05909991534387 ¦ Rp ¦ 153654\n100 tabl.",
  "substance": "Zolpidemi tartras 10 mg",
  "common_name": "Zolpidemi tartras",
  "pl_product_id": "100494680",
  "pozwolenie_nr": "107/24",
  "auth_procedure": "IR",
  "authorisation_validity": "2029-03-13"
}
API referenceMCP serverPlans

See everything about zolpidem.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console